The document is a startup identification report focusing on the field of onco-immunotherapy, outlining over 110 startups established between 2010 and 2019, including their activities, technologies, funding, and key personnel. It emphasizes the importance of utilizing patent data to uncover startups and assess their technological capabilities and personnel backgrounds. The report also highlights the growing significance of immunotherapy in oncology, projecting substantial market growth due to increasing cancer incidences and the need for innovative treatments.